Biocept Expands its Menu of Molecular Assay Kit Offering with Release of its Target Selector™ BRAF Kit for Clients’ Use in Their Own Laboratories
- Thursday, May 14, 2020, 7:14
- Environment
- Add a comment
SAN DIEGO, May 14, 2020 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the availability of a…
About the Author
adminasapcorp has written 41775 stories on this site.